Ovarian cancer remains a deadly disease. This is due to a combination of late stage discovery and marginally effective therapy, resulting from both inherent and acquired treatment resistance. Failure of conventional approaches to provide effective treatment for this ovarian cancer suggests that new ways of thinking are required. Our preliminary observations show that ovarian tumor cells acquire and retain more iron than their non-malignant counterparts. Evidence of enhanced iron utilization is evident in ovarian tumor tissue and in ovarian tumor progenitor cells. We hypothesize that ovarian cancer cells become dependent on maintaining supra-normal levels of metabolically available intracellular iron to support their growth and viability. We propose the term iron addiction to characterize this state. Altered iron metabolism may represent a new targetable hallmark of cancer. We propose three specific aims to test this hypothesis.
In Aim 1, key differences in iron metabolism between normal ovarian stem cells and ovarian tumor progenitor cells derived from patient samples will be characterized using RNAseq and proteomics. The roles of these proteins in pathways essential to cancer cell iron metabolism will be determined.
In Aim 2, alterations in oncogenic signaling that drive critical differences in iron metabolism in ovarian tumor progenitor cells will be assessed by interrogating the role of c-myc. Analysis of patient databases will be used to assess prevalence of c-myc-driven changes in iron metabolism and association with prognosis.
Aim 3, we will use systems biology to identify key iron regulatory nodes and mechanisms through which other oncogenic drivers target iron. The overall goal of this proposal is to understand mechanisms underlying iron addiction in ovarian cancer and how changes in iron metabolism link to oncogenic signaling. This may provide insights into new and novel targets for ovarian cancer therapy.
Ovarian cancer is poorly understood, and treatments are limited. The goal of this proposal is to examine how and why iron metabolism is altered when ovarian cells become malignant. This may provide insights into new and novel targets for ovarian cancer therapy.
|Blanchette-Farra, Nicole; Kita, Daniel; Konstorum, Anna et al. (2018) Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer. Oncogene 37:4013-4032|
|Konstorum, Anna; Lynch, Miranda L; Torti, Suzy V et al. (2018) A Systems Biology Approach to Understanding the Pathophysiology of High-Grade Serous Ovarian Cancer: Focus on Iron and Fatty Acid Metabolism. OMICS 22:502-513|
|Chifman, Julia; Arat, Seda; Deng, Zhiyong et al. (2017) Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective. PLoS Comput Biol 13:e1005352|
|Basuli, D; Tesfay, L; Deng, Z et al. (2017) Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene 36:4089-4099|
|Deng, Zhiyong; Manz, David H; Torti, Suzy V et al. (2017) Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth. Oncotarget 8:82231-82243|
|Lemler, David J; Lynch, Miranda L; Tesfay, Lia et al. (2017) DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Res 19:25|
|Paul, Bibbin T; Manz, David H; Torti, Frank M et al. (2017) Mitochondria and Iron: current questions. Expert Rev Hematol 10:65-79|
|Stockwell, Brent R; Friedmann Angeli, José Pedro; Bayir, Hülya et al. (2017) Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171:273-285|
|Torti, S V; Lemler, E; Mueller, B K et al. (2016) Effects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor Xenografts. Clin Exp Pharmacol 6:|
|Yamamoto, Yusuke; Ning, Gang; Howitt, Brooke E et al. (2016) In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells. J Pathol 238:519-530|
Showing the most recent 10 out of 13 publications